TET2 and myeloproliferative neoplasm: We speculated that, in addition to TET2 deletion, JAK2V617F mutation itself was also an important factor inducing increased IL‐1β expression in patients with MPN, and increased IL‐1β may be one of the important mechanisms of concomitant AF in patients with JAK2V617F‐positive MPN.